2m 2m 2m 2m 2m 2m 2m
Alkermes (ALKS)
NASDAQ
$51.86-$0.010 (-0.02%)
Price as of Jul 13, 2026 7:25 PM EDT- $8.6BMarket Cap
- 74.71%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alkermes (ALKS)
$51.86-$0.010 (-0.02%)
ALKS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $51.87 | ||
Change | -$0.07 (-0.13%) | ||
Open | $51.07 | ||
High | $52.00 | ||
Low | $50.54 | ||
Previous Close | $51.94 | ||
Volume | 1,583,737 | ||
30-Day Average Volume | 2,731,674 | ||
1-Week Change | -5.93% | ||
1-Month Change | 17.14% | ||
1-Year Change | 74.71% | ||
3-Year Change | 72.84% | ||
5-Year Change | 112.23% | ||
Fundamentals | |||
Shares Outstanding | 164.8M | ||
Total Assets | $4.3B | ||
Market Cap | $8.6B | ||
Enterprise Value | $9.7B | ||
Period: QTR TTM FY | |||
Revenue | $39.5M | ||
Net Income | $16.2M | ||
Free Cash Flow | -$169.8M | ||
EBIT | $28.5M | ||
EBITDA | $47.9M | ||
Net Working Capital | $759.1M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | 203 | ||
Enterprise Value/Revenue | 246 | ||
P/B | 5 | ||
P/E | -130 | ||
PEG | 1 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue